Dexmedetomidine Versus Nefopam for management of post spinal anesthesia shivering:A randomized double-blind controlled study
Phase 1
Completed
- Conditions
- Post spinal anesthesia shiveringAnaesthesiology - Anaesthetics
- Registration Number
- ACTRN12614001124628
- Lead Sponsor
- South valley university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
ASA I and II patients scheduled for elective lower abdominal,lower limb , orthopedic and plastic surgeries under spinal anesthesia
Exclusion Criteria
Known hypersensitivity to dexmedetomidine or Nefopam,cardiopulmonary,renal or hepatic diseases,patients with a contra indication to spinal anesthesia e.g coagulation disorders,patients with failed or partial spinal block or those who do not agree to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of stoppage of postspinal anesthesia shivering after treatment with either dexmedetomidine or Nefopam.[We record shivering every minute after I. V. Injection of either dexmedetomidine or Nefopam for the first five minutes of the injections and record time of its stoppage after treatment.]
- Secondary Outcome Measures
Name Time Method Duration of effective postspinal analgesia after treatment with either dexmedetomidine or Nefopam. It is calculated from intrathecal bupivacaine injection to patient first request for rescue analgesic guided by visual analogue scale . Adverse effects are not outcome of the study.[Duration of effective postspinal analgesia from intrathecal bupivacaine administration to first rescue analgesic request.]